Abstract
The QCA‐1 molecule (quiescent cell antigen‐1) appears to be involved in the differentiation events undergone by T cell following occupancy of the antigen receptor. Here we show that modulation of the QCA‐1 antigen from the surface of the cell normally follows activation, and that treatment of animals with the antibodies against the QCA‐1 molecule inhibits the normal response to an allograft without appearing to alter the number of peripheral T cells or the expression by these cells of the α/β T cell antigen receptor.
| Original language | English |
|---|---|
| Pages (from-to) | 3053-3056 |
| Number of pages | 4 |
| Journal | European Journal of Immunology |
| Volume | 21 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - Dec 1991 |
| Externally published | Yes |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Fingerprint Dive into the research topics of 'Prolonged survival of skin grafts following treatment with an antibody to a putative cell triggering molecule, QCA‐1'. Together they form a unique fingerprint.
Cite this
Aspinall, R., Kampinga, J., & Van Den Bogaerde, J. (1991). Prolonged survival of skin grafts following treatment with an antibody to a putative cell triggering molecule, QCA‐1. European Journal of Immunology, 21(12), 3053-3056. https://doi.org/10.1002/eji.1830211224